Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04105699 · ClinicalTrials.gov registry record

Evaluation of Immunoassay Measurements of Pancreatic Stone Protein Performed on abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis

A clinical trial of Sepsis, sponsored by Abionic.

Completed
Registry status
544
Enrollment target
5
Study locations

NCT04105699 is a study of Sepsis that has completed, run by Abionic. The registered enrollment target is 544 participants, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04105699, a study of Sepsis, has completed, sponsored by Abionic.

COMPLETED
Registry status
544 participants
Enrollment target
5
Study locations

Study Summary

This is a multicenter, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on ICU patients at risk of sepsis as an aid in identifying sepsis.

Conditions Studied

Sepsis

Interventions

  • DEVICE Blood sampling

Study Locations (5)

Illinois

  • Northwestern University - Chicago
  • Rush University Medical Center - Chicago

Kentucky

  • University of Kentucky - Lexington

Ohio

  • Mercy Health St. Vincent - Toledo

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 544 participants
Start Date 2019-12-10
Est. Completion 2023-12-28

Sponsor

Abionic

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04105699

The ClinicalTrials.gov registry entry for NCT04105699 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 544 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower). The listed sponsor is Abionic, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Blood sampling is the first listed.

NCT04105699 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Illinois, Kentucky, Ohio.

Frequently Asked Questions

What is clinical trial NCT04105699 about?

NCT04105699 is a clinical study titled "Evaluation of Immunoassay Measurements of Pancreatic Stone Protein Performed on abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis". This is a multicenter, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on ICU patients at risk of sepsis as an aid in identifying sepsis.

What is the current status of trial NCT04105699?

This trial is currently completed. The enrollment target is 544 participants. The study started on 2019-12-10. Estimated completion is 2023-12-28.

What conditions does trial NCT04105699 study?

This clinical trial studies the following conditions: Sepsis.

What interventions are being tested in trial NCT04105699?

The interventions under investigation include: Blood sampling (DEVICE).

Who is sponsoring clinical trial NCT04105699?

This trial is sponsored by Abionic, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04105699 being conducted?

This trial has 5 study locations across Illinois, Kentucky, Ohio, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sepsis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sepsis

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.